| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | tacrolimus | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | BRD-K66532283 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Bexarotene | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | pandacostat | CTRPv2 | pan-cancer | AAC | 0.0012 | 1 |